Global Market for Genome Editing to Nearly Quadruple by 2023

Technological Breakthrough Enables More Applications in Many Industries

February 22, 2019

WELLESLEY, Mass., February 22, 2019 – Despite its controversy, genome editing—a type of genetic engineering where DNA is inserted, replaced or removed from a genome by using artificially engineered nucleases—is solidifying itself as a promising tool researcher can use to understand and treat a variety of genetic diseases, alter crops and more. Thanks to the discovery of genome editing technology called CRISPR-Cas, which performs a cut-and-paste function to delete, edit or replace DNA, more industries are becoming interested in genome editing, creating significant opportunities for growth in the global market over the next five years.

The global market for genome editing was valued at roughly $1.4 billion in 2018 and is expected to reach approximately $4.4 billion in 2023 at a compound annual growth rate (CAGR) of 25.7%, according to a new report by BCC Research, "Genome Editing: Technologies and Global Markets."

Top competitors in the industry include a mix of life science tools companies, genetic engineering startups, biotech companies, and more, including Thermo Fisher Scientific (TMO), MilliporeSigma, 2Blades Foundation and ABclonal.

Report Highlights

  • Market region analysis. The U.S. will continue to lead the genome editing market, with a forecasted value of over $1.7 billion in 2023, indicating a CAGR of 26.6%.
  • Top market applications. The rapid growth of the genome editing market will be driven by four main application segments: academic research, drug discovery and development, clinical therapy and non-transgenic breeding, with drug discovery being the leading application.
  • Technology market analysis. As a game-changer in genome editing technology, CRISPR-Cas was valued at roughly $1.0 billion in 2018, and is expected to grow rapidly to nearly $3.4 billion by 2023, with a five-year CAGR of 27.2%. 

“Genome editing is revolutionizing many biology-related areas where a wide range of applications are driving the growth of the genome editing market,” said BCC Research analyst Mike Fan. “Currently, this market is continuing its rapid exponential growth. All major regional markets in the world will quickly grow.”

Barriers to Market Growth

Is it ethical to alter human life? What are the consequences of reshaping human beings? These are just a few of the questions that researchers must consider when exploring genome editing, and questions that slow the growth of the global market. Other barriers to the market’s growth include stringent regulatory requirements on clinical applications that slow the approval process, patent disputes, differing governmental policies and regulations, and ambiguous regulations around using genome editing techniques to develop economically useful crop traits.

Editors/reporters requesting analyst interviews should contact Eric Surber at

Genome Editing: Technologies and Global Markets( BIO146B )
Publish Date: Feb 2019    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.